Correction: Cusip for Credit Suisse's RevCons on Gilead is 22547QN85

A story in the May 14 edition of the Prospect News Structured Products Daily included an incorrect Cusip number for Credit Suisse's upcoming autocallable reverse convertible securities linked to the common stock of Gilead Sciences, Inc. A corrected version of the story follows.

By Marisa Wong

Madison, Wis., May 16 - Credit Suisse AG plans to price 8% autocallable reverse convertible securities due May 26, 2015 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable monthly.

The notes will be called at par if Gilead shares close at or above the initial share price on Nov. 19, 2014 or Feb. 18, 2015.

The payout at maturity will be par unless Gilead shares close at or below the knock-in price, 70% of the initial share price, during the life of the notes and finish below the initial share price, in which case the payout will be a number of Gilead shares equal to $1,000 divided by the initial share price.

Credit Suisse Securities (USA) LLC is the agent.

The notes will price on May 20 and settle on May 23.

The Cusip number is 22547QN85.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.